PillRx only · Solution/ Drops · Ophthalmic
Diclofenac Sodium
Brands: Diclofenac · Diclofenac Sodium
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.706
Latest avg · Jul 22, 2026
-15%
Since Dec 17, 2025
3
Active US suppliers
80%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
3.1K
Rx · 2026 Q1
16K
Units dispensed
-47%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bausch & Lomb Incorporated | unknown | 2 | SUPPLYING |
| Altaire Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 2, 2019RECALLRecall (Class II): Altaire Diclofenac Sodium Opthalmic Solution, 0.1%, 2.5 mL, Rx only, Manufactured Altaire Pharmaceuticals, NDC 59390-14…
Lack of Assurance of Sterility — Recalling firm: Altaire Pharmaceuticals, Inc. — U.S.A. Nationwide
- Jul 2, 2019RECALLRecall (Class II): Altaire Diclofenac Sodium Opthalmic Solution, 0.1%, 5 mL, Rx only, Manufactured Altaire Pharmaceuticals, NDC 59390-149-…
Lack of Assurance of Sterility — Recalling firm: Altaire Pharmaceuticals, Inc. — U.S.A. Nationwide